| VINC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the VINC shares outstanding history going back to 11/6/2020:
Also see: VINC Market Cap History VINC YTD Return |
As of 4/30/2025 Vincera Pharma has 5.23 million VINC shares outstanding. Investors often track the VINC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VINC share count trends over time, with 17 historical shares outstanding datapoints presented, dating back to 11/6/2020.

| VINC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||
Below is a table of the VINC shares outstanding history going back to 11/6/2020:
Also see: VINC Market Cap History VINC YTD Return |
| VINC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||
VINC Historical Shares Outstanding: +76.55% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||
| VINC Stock Price Chart |
| About Vincerx Pharma Inc |
| Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9 inhibitor). VIP943 is a potential anti-CD123 ADC created with its VersAptx Platform. It consists of an anti-CD123 antibody, a novel legumain-cleavable linker, and a KSPi payload enhanced with its CellTrapper technology. We show 17 historical shares outstanding datapoints in our coverage of VINC's shares outstanding history. Understanding the changing numbers of VINC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VINC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VINC by allowing them to research VINC shares outstanding history as well as any other stock in our coverage universe. |
| VINC Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VINC Share Performance |
| Shares Outstanding Peers |
| Vincera Pharma (VINC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VIR Shares Outstanding History VIRI Shares Outstanding History VIRX Shares Outstanding History VIVE Shares Outstanding History VIVK Shares Outstanding History VIVO Shares Outstanding History VIVS Shares Outstanding History VKTX Shares Outstanding History VLON Shares Outstanding History VLRX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.